Event: Global Biopharmaceutical Outsourcing: Improving R&D Productivity and Cost Performance
Organizer: Strategic Research Institute
Dates: February 25 to 26, 2008
Venue: The Loews Philadelphia Hotel - Philadelphia, PA

Both small and large pharmaceutical firms are tapping the low-cost global pharmaceutical outsourcing market for both research and manufacturing.  It is estimated that the global outsourcing market will surpass $53 billion by 2010. 

Global Biopharmaceutical Outsourcing provides in-depth explorations of the hottest topics in the market in your own back yard.  This two day, intensive event covers the essential and vital information you need to keep your projects on track while minimizing costs. 

The following key issues are covered:

- Develop and understand local regulatory practices with sites and investigators in China, India, Brazil and Europe

- Outsourcing capabilities and critical IP in China, India, Hong Kong, Taiwan, Singapore, Latin America and Europe

- Overcome obstacles in study start-up: per subject costing, investigator contract and budget negotiations, regulatory document collection and consultant agreement negotiation

- Selecting the right clinical and preclinical approaches: Individual and Multi-project outsourcing

- Streamlining outsourcing partnerships: who owns what and who bears the liability

- Outsourcing drug safety and toxicology to China

- CRO evaluations and due diligence

For more information, please contact:
Ms. Cheryl Kahan-Radhuber
Strategic Research Institute
333 Seventh Avenue
New York, NY  10001
tel: (212) 967-0095, ext. 273
fax: (212) 967-7973
E-mail: CKahan-Radhuber@srinstitute.com